Related Experiment Video
Updated: Jul 31, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Impact of repeat revascularization within 5 years on 10-year mortality after percutaneous or surgical
Rutao Wang1,2,3, Mattia Lunardi4,5, Hironori Hara2,6
1Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
Insights
Repeat revascularization within 5 years did not impact overall 10-year mortality for patients with complex coronary artery disease. However, those needing repeat procedures after initial PCI faced higher mortality than after CABG.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Clinical Trials
Background:
- The SYNTAX trial indicated repeat revascularization (RR) negatively impacts 5-year outcomes in 3-vessel disease (3VD) and/or left main coronary artery disease (LMCAD).
- The SYNTAXES study aimed to assess the 10-year mortality impact of RR within 5 years in these patients.
Purpose of the Study:
- To evaluate the effect of repeat revascularization within 5 years on 10-year all-cause mortality.
- To compare outcomes between Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG) in patients requiring repeat procedures.
Main Methods:
- The SYNTAXES study analyzed 10-year vital status data from patients with 3VD and/or LMCAD.
- Patients were stratified based on whether they underwent repeat revascularization within 5 years and their initial randomized treatment (PCI vs. CABG).
- Statistical analysis assessed the association between repeat revascularization and 10-year mortality.
Main Results:
- 18.3% of patients underwent repeat revascularization within 5 years; it was more frequent after initial PCI (25.9%) than CABG (13.7%).
- Overall 10-year mortality was similar between patients with and without repeat revascularization (28.2% vs. 26.1%).
- Among patients requiring repeat procedures, initial PCI was associated with higher 10-year mortality (33.5%) compared to initial CABG (17.6%, adjusted HR: 2.09).
Conclusions:
- Repeat revascularization within 5 years did not significantly impact overall 10-year mortality in the studied population.
- For patients requiring repeat procedures, initial PCI was linked to a higher risk of 10-year mortality compared to initial CABG.
- Further investigation in larger cohorts is warranted to confirm these exploratory findings.
Background:
The SYNTAX trial demonstrated negative impact of repeat revascularization (RR) on 5-year outcomes following PCI/CABG in patients with three-vessel(3VD) and/or left main coronary artery disease(LMCAD). We aimed to investigate the impact of RR within 5 years, on 10-year mortality in patients with 3VD and/or LMCAD after PCI/CABG.
Methods:
The SYNTAXES study evaluated the vital status out to 10 years of patients with 3VD and/or LMCAD. Patients were stratified by RR within 5 years and randomized treatment. The association between RR within 5 years and 10-year mortality was assessed.
Results:
A total of 330 out of 1800 patients (18.3%) underwent RR within 5 years. RR occurred more frequently after initial PCI than after initial CABG (25.9% vs. 13.7%, p < 0.001). Overall, 10-year mortality was comparable between patients undergoing RR and those not (28.2% vs. 26.1%, adjusted HR: 1.17, 95%CI 0.93-1.48, p = 0.187). In the PCI arm, RR was associated with a trend toward higher 10-year mortality (adjusted HR: 1.29, 95%CI 0.97-1.72, p = 0.075), while in the CABG arm, the trend was opposite (adjusted HR: 0.74, 95%CI 0.46-1.20, p = 0.219). Among patients requiring RR, those who underwent PCI as initial revascularization had a higher risk of 10-year mortality compared to initial CABG (33.5% vs. 17.6%, adjusted HR: 2.09, 95%CI 1.21-3.61, p = 0.008).
Conclusion:
In the SYNTAXES study, RR within 5 years had no impact on 10-year all-cause death in the population overall. Among patients requiring any repeat procedures, 10-year mortality was higher after initial treatment with PCI than after CABG. These exploratory findings should be investigated with larger populations in future studies.
Trial Registration:
URL: https://www.
Clinicaltrials:
gov ; SYNTAXES Unique identifier: NCT03417050. URL: https://www.
Clinicaltrials:
gov ; SYNTAX Unique identifier: NCT00114972.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care

